- PDLI Ticker
- 🇺🇸 NASDAQ 兑换
- 87 员工
- 💊 Health Care 部门
- 🧪 Biotechnology 工业
- Dominique Monnet 首席执行官
4 评价
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
财务报表 — PDL BioPharma
这些信息不是100%最新的。可能存在错误或信息缺失。有些信息经常丢失,虽然几乎没有错误,但我不能排除它们。现在,我正在寻找一个高质量的信息供应商,但到目前为止,我发现的是昂贵的（大约2000美元一年）。您可以帮助我的项目这里。
| 19 ← 15 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|
| 總收入 |
|
55M | 200M | 320M | 240M | 590M |
| 收益成本 |
|
54M | 48M | 31M | 4.1M | 0 |
| 毛利 |
|
1.1M | 150M | 290M | 240M | 590M |
| 研究與開發 |
|
7.3M | 3M | 7.4M | 3.8M | 0 |
| 出售一般和管理員 |
|
54M | 63M | 63M | 40M | 36M |
| 運營開支 |
|
120M | 130M | 130M | 60M | 36M |
| 營業收入 |
|
-67M | 68M | 190M | 180M | 550M |
| 其他收入支出淨額 |
|
0 | 0 | 0 | 0 | 0 |
| EBIT |
|
-30M | 68M | 190M | 180M | 550M |
| 利息收入 |
|
11M | 12M | 20M | 18M | 27M |
| 稅前收入 |
|
-74M | -56M | 180M | 110M | 530M |
| 所得稅 |
|
-3M | 13M | 74M | 46M | 200M |
| 少數權益 |
|
-280K | 0 | -47K | 53K | 0 |
| 淨收入 |
|
-70M | -69M | 110M | 64M | 330M |
| 淨收入基本 |
|
-70M | -69M | 110M | 64M | 330M |
| 19 ← 15 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|
| 當前現金 |
|
190M | 390M | 530M | 170M | 220M |
| 短期投資 |
|
15M | 19M | 14M | 77M | 3M |
| 應收款 |
|
66M | 85M | 85M | 150M | 58M |
| 庫存 |
|
40M | 19M | 9.1M | 2.9M | 0 |
| 其他流動資產 |
|
15M | 19M | 14M | 77M | 3M |
| 當前資產 |
|
310M | 520M | 640M | 400M | 280M |
| 長期投資 |
|
400M | 450M | 600M | 820M | 730M |
| 物業設備 |
|
5.5M | 7.4M | 7.2M | 38K | 31K |
| 商譽 |
|
0 | 0 | 0 | 0 | 0 |
| 無形資產 |
|
290M | 430M | 570M | 630M | 400M |
| 其他資產 |
|
25M | 9.8M | 28M | 170M | 320M |
| 總資產 |
|
720M | 960M | 1.2B | 1.2B | 1B |
| 應付賬款 |
|
17M | 13M | 20M | 7M | 390K |
| 當前長期債務 |
|
0 | 0 | 130M | 88M | 25M |
| 其他流動負債 |
|
28M | 39M | 47M | 35M | 11M |
| 總流動負債 |
|
46M | 52M | 190M | 130M | 37M |
| 長期債務 |
|
27M | 120M | 120M | 230M | 230M |
| 其他負債 |
|
49M | 43M | 86M | 97M | 51M |
| 少數權益 |
|
78K | 0 | 0 | 4.3M | 0 |
| 負債總額 |
|
120M | 230M | 400M | 460M | 320M |
| 普通股 |
|
-78M | -97M | -100M | -110M | -120M |
| 留存收益 |
|
670M | 830M | 950M | 860M | 810M |
| 庫存庫存 |
|
0 | -2.1M | 0 | 0 | 0 |
| 資本盈餘 |
|
• | • | • | • | • |
| 股東權益 |
|
590M | 730M | 850M | 750M | 700M |
| 有形淨資產 |
|
300M | 300M | 280M | 120M | 300M |
| 19 ← 15 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|
| 淨收入 |
|
-70M | -69M | 110M | 64M | 330M |
| 折舊 |
|
6.3M | 16M | 25M | 12M | 0 |
| 應收款變動 |
|
-19M | -110K | -67M | 93M | 500K |
| 庫存變化 |
|
21M | 9.8M | 6.3M | 2.9M | 0 |
| 現金找零 |
|
-200M | -140M | 360M | -53M | -73M |
| 現金流量 |
|
32M | 13M | 41M | 100M | 300M |
| 資本支出 |
|
-760K | -4.5M | -1.3M | -25K | -9K |
| 投資 |
|
• | • | • | • | • |
| 投資其他活動 |
|
• | • | • | • | • |
| 總投資現金流量 |
|
22M | 57M | 460M | -140M | -80M |
| 已付股息 |
|
9K | • | • | • | • |
| 淨借款 |
|
-180M | -290M | -300M | 77M | 34M |
| 其他籌資現金流量 |
|
• | • | • | • | • |
| 現金流量融資 |
|
-190M | -180M | -120M | -29M | -290M |
| 匯率影響 |
|
• | • | • | • | • |
生产和销售生物制药产品